查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
动物感染疾病诊断的全球市场:现状分析、预测 (2022年～2028年)
市场调查报告书
商品编码
1241363

动物感染疾病诊断的全球市场:现状分析、预测 (2022年～2028年)

Global Veterinary Infectious Disease Diagnostics Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于动物传染病很难诊断，因此进行了广泛的研究，这推动了动物传染病诊断市场的成长。此外，饲养动物数量增加和传染病的流行也促进了市场的成长。由于私营公司和政府之间的合作，预计动物传染病诊断市场将以8%左右的速度稳定成长。

本报告提供全球动物感染疾病诊断的市场调查，市场定义和概要，市场成长的各种影响因素分析，市场规模的变化、预测，各种区分、各地区/主要国家的明细，法律制度，供需趋势，竞争环境，主要企业简介等彙整资讯。

目录

第1章 简介

第2章 调查手法、前提条件

第3章 市场概要

第4章 摘要整理

第5章 COVID-19:对动物感染疾病诊断市场的影响

第6章 动物感染疾病诊断市场:收益的变化、预测

第7章 市场洞察:各技术

  • 免疫诊断
  • 分子诊断
  • 其他

第8章 市场洞察:各类型

  • 宠物
  • 食品生产动物

第9章 市场洞察:各感染类型

  • 细菌感染疾病
  • 病毒感染疾病
  • 寄生虫感染疾病
  • 其他

第10章 市场洞察:各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第11章 动物感染疾病诊断市场:市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第12章 动物感染疾病诊断市场:市场机会

第13章 动物感染疾病诊断市场:市场趋势

第14章 需求侧、供给侧的分析

第15章 价值链分析

第16章 竞争模式

第17章 企业简介

  • BIOMERIEUX
  • Heska Corporation
  • IDEXX
  • Innovative Diagnostics
  • INDICAL BIOSCIENCE GmbH
  • Neogen Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific
  • Virbac
  • Zoetis

第18章 免责声明

简介目录
Product Code: UMME211680

Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. The frequently occurring infectious diseases in animals are avian influenza virus and rabies virus. The diagnosis of infectious diseases is extremely difficult owing to the lack of symptoms in the animals. Therefore, huge research has been done in the sector, thus driving the growth of the market. Moreover, The rising adoption of animals and the increasing prevalence of infectious diseases among them are attributed to the market growth of the veterinary infectious disease diagnostics market. For instance, according to the Centers for Disease Control (CDC), Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals.

The Veterinary Infectious Disease Diagnostics Market is expected to grow at a steady rate of around 8% owing to the collaboration of private companies and governments. For instance, in January 2023, Alveo Technologies and the government of Barbados collaborate to co-develop advanced molecular disease diagnostics across multiple end markets.

Based on the technology, the market has been categorized into immunodiagnostics, molecular diagnostics, and others. Among them, the immunodiagnostics segment held a dominant share of the market in 2021. Immunodiagnostics is a technique of detection by using the ability of antibodies to bind to an antigen specifically. Factors such as the high efficiency of the technique, its cost-effective method of diagnostics, and it provides fast results are responsible for the dominating share of the segment.

Based on the animal type, the market has been categorized into companion animals and food-producing animals. Among them, the companion animals segment is anticipated to witness the fastest growth in the market. The increasing adoption of the companion animals such as dogs and cats is an important reason for the growth of the companion animal segment. For instance, according to the Zebra survey, 12.8% of Americans adopted a pet in 2020.

Based on the infection type, the market has been categorized into bacterial infections, viral infections, parasitic infections, and others. Among them, the parasitic infections segment holds a prominent share of the market. This is mainly owing to the increasing number of parasitic infections such as Ehrlichiosis and helminths in animals.

For a better understanding of the market adoption of the veterinary infectious disease diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated held a dominant market share in 2020. This is mainly due to the initiative taken by governmental organizations, higher adoption of pets, and favorable pet insurance policies. For instance, as per NAPHIA's 2022 State of the Industry Report, more than 4.41 million pets were insured in North America in 2021, up from 3.45 million in 2020.

Some of the major players operating in the market are BIOMERIEUX; Heska Corporation; IDEXX; Innovative Diagnostics; INDICAL BIOSCIENCE GmbH; Neogen Corporation; Randox Laboratories Ltd.; Thermo Fisher Scientific; Virbac.; and Zoetis.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Veterinary Infectious Disease Diagnostics Market
  • 2.2. Research Methodology of the Veterinary Infectious Disease Diagnostics Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TECHNOLOGY

  • 7.1. Immunodiagnostics
  • 7.2. Molecular Diagnostics
  • 7.3. Others

8 MARKET INSIGHTS BY ANIMAL TYPE

  • 8.1. Companion Animals
  • 8.2. Food-Producing Animals

9 MARKET INSIGHTS BY INFECTION TYPE

  • 9.1. Bacterial Infections
  • 9.2. Viral Infections
  • 9.3. Parasitic Infections
  • 9.4. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OPPORTUNITIES

13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. BIOMERIEUX
  • 17.2. Heska Corporation
  • 17.3. IDEXX
  • 17.4. Innovative Diagnostics
  • 17.5. INDICAL BIOSCIENCE GmbH
  • 17.6. Neogen Corporation
  • 17.7. Randox Laboratories Ltd.
  • 17.8. Thermo Fisher Scientific
  • 17.9. Virbac
  • 17.10. Zoetis

18 DISCLAIMER